In the literature, it was shown, that the GTPase Rab7, which is currently gaining importance as an oncosuppressor (54), impairs TLR4 by promoting its lysosomal degradation (54) and may therefore play a role in immune-suppressive mechanisms during cancer progression and cachexia development. This evidence concerns the gene TLR4 and cancer.